Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorMehmet, K.
dc.contributor.authorAlper, E.M.
dc.contributor.authorOytun, E.
dc.date.accessioned2022-11-04T19:55:49Z
dc.date.available2022-11-04T19:55:49Z
dc.date.issued2022
dc.identifier.issn0006-9248
dc.identifier.urihttps://doi.org/10.4149/BLL_2022_104
dc.identifier.urihttp://hdl.handle.net/11446/4638
dc.description.abstractEpilepsy is a widespread and mainly severe neurological condition portrayed by recurring spontaneous seizures caused by the brain’s abnormal electrical activity. According to new research, infl ammation may be both a result and the cause of epileptic seizures. The highest zinc levels in the brain have been found in the hippocampus which is one of the most studied regions of the brain regarding epilepsy. Zinc may have an anti-infl ammatory potential as zinc co-factors affect numerous biochemical and physiological reactions. In this study, we evaluated the effects of intraperitoneal zinc administration on seizure activity in murine PTZ model. Rats received either intraperitoneal (IP) zinc sulfate at two different dosages (50–100 mg/kg) or a placebo followed by pentylenetetrazole (IP), a strong seizure-inducing drug. The spike percentages were considerably lower in the PTZ (35 mg/kg) and 50 or 100 mg/kg zinc-treated groups (A3 and A4) than in the PTZ (35 mg/kg) and saline-treated group (A2; p < 0.001). When the PTZ (70 mg/kg) and zinc sulfate-administered groups (B3 and B4) were compared to the PTZ (70 mg/kg) group (B2), the zinc-administered groups had a substantially reduced RCS (p < 0.001). The onset time of FMJ was substantially longer in the PTZ (70 mg/ kg) and 50 mg/kg or 100 mg/kg zinc sulfate groups (B3 and B4) than in the PTZ (70 mg/kg) and saline (B2; p < 0.001). We discovered that MDA levels were considerably lower in the zinc-treated groups. SOD and HSP-70 levels were also increased signifi cantly with zinc sulfate administration. In conclusion, our fi ndings indicate that zinc has the potential to exhibit antiepileptogenic effects by alleviating acute oxidative stress and neuroinfl ammation in a rat PTZ-induced epilepsy model. Zinc (50 or 100 mg/kg i.p.) successfully decreased the spike percentages and RCS associated with PTZ kindling epilepsy, as well as considerably decreased MDA and increased SOD and HSP-70 levels in rat brain. According to these results, zinc sulfate may be used as an adjuvant therapy in combination with other antiepileptic drugs in the future © 2022. Bratislava Medical Journal. All Rights Reserved.en_US
dc.language.isoengen_US
dc.publisherComenius University in Bratislavaen_US
dc.relation.ispartofBratislava Medical Journalen_US
dc.identifier.doi10.4149/BLL_2022_104en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAbnormal electrical activityen_US
dc.subjectAnti-seizure effect of zincen_US
dc.subjectAntiepileptic drugsen_US
dc.subjectEpilepsyen_US
dc.subjectRat modelen_US
dc.subjectanticonvulsive agenten_US
dc.subjectpentetrazoleen_US
dc.subjectzincen_US
dc.subjectanimalen_US
dc.subjectdisease modelen_US
dc.subjectepilepsyen_US
dc.subjecthippocampusen_US
dc.subjectmouseen_US
dc.subjectraten_US
dc.subjectAnimalsen_US
dc.subjectAnticonvulsantsen_US
dc.subjectDisease Models, Animalen_US
dc.subjectEpilepsyen_US
dc.subjectHippocampusen_US
dc.subjectMiceen_US
dc.subjectPentylenetetrazoleen_US
dc.subjectRatsen_US
dc.subjectZincen_US
dc.titleAnti-seizure effect of zinc on PTZ-induced epilepsy in rat modelen_US
dc.typearticleen_US
dc.identifier.issue9en_US
dc.identifier.volume123en_US
dc.identifier.startpage648en_US
dc.identifier.endpage652en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-tempMehmet, K., Izmir Katip Celebi University, Faculty of Medicine, Department of Physiology, Izmir, Turkey; Alper, E.M., Izmir Katip Celebi University, Faculty of Medicine, Department of Physiology, Izmir, Turkey; Oytun, E., Bilim University, Faculty of Medicine, Department of Physiology, Istanbul, Turkeyen_US
dc.identifier.pmid36039883en_US
dc.identifier.scopus2-s2.0-85135866027en_US
dc.authorscopusid57841962900
dc.authorscopusid57843147900
dc.authorscopusid57841377300


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster